Article: Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: April 21-June 16, 2005.

Article: Inte:Ligand and Molecular Networks Announce the Integration of ...
Business Wire;  April 26, 2005 ;     685 words ... ... dimensional molecular models, into ILIB DIVERSE, the high quality virtual compound ... technology for mutual benefit in the future. ILIB DIVERSE generates libraries of drug-like chemical ... properties. By integrating CORINA into ILIB DIVERSE, high-quality virtual libraries of ...

Article: Seattle Genetics Achieves Milestones Under ...
Business Wire;  June 17, 2003 ;     700+ words ... ... BUSINESS WIRE)--June 17, 2003 Seattle Genetics, Inc. (Nasdaq:SGEN) announced ... which trigger certain payments to Seattle Genetics. The two companies formed the collaboration ... provide Celltech with a license to Seattle Genetics' ADC technology for use with Celltech ...

Article: Seattle Genetics Announces Antibody-Drug Conjugate ...
Business Wire;  April 22, 2002 ;     700+ words ... ... BW HealthWire)--April 22, 2002 Seattle Genetics, Inc. (Nasdaq:SGEN) today announced ... Inc. (NYSE:DNA) has licensed Seattle Genetics' proprietary antibody-drug conjugate ... provides Genentech with broad access to Seattle Genetics' ADC technology for use with therapeutic ...

Article: Seattle Genetics Announces Appointment of Clay B. ...
Business Wire;  November 27, 2002 ;     700+ words ... ... the Board and Chief Strategy Officer Seattle Genetics, Inc. (Nasdaq:SGEN) announced ... Together, Perry and Clay have built Seattle Genetics from a start-up to a publicly ... Powell, Ph.D., a member of Seattle Genetics' Board of Directors and managing ...

Article: Seattle Genetics Announces Antibody-Drug Conjugate ...
Business Wire;  September 28, 2004 ;     700+ words ...BOTHELL, Wash. -- Seattle Genetics, Inc. (Nasdaq:SGEN) announced ... NYSE:BAY) has licensed Seattle Genetics' proprietary antibody-drug ... Bayer with rights to utilize Seattle Genetics' ADC technology to link cell ...

Article: Seattle Genetics Launches Manufacturing Campaign ...
Business Wire;  May 5, 2005 ;     700+ words ...BOTHELL, Wash. -- Seattle Genetics, Inc. (Nasdaq:SGEN) announced ... auristatin derivative using Seattle Genetics' second generation ADC technology ... Chief Executive Officer of Seattle Genetics. "We are pleased to extend ...

Article: Seattle Genetics and MedImmune Expand Antibody-Drug ...
Business Wire;  October 31, 2007 ;     700+ words ...BOTHELL, Wash. -- Seattle Genetics, Inc. (NASDAQ:SGEN), announced today that MedImmune ... collaboration, triggering a $1.5 million payment to Seattle Genetics. Seattle Genetics' ADC technology empowers antibodies by linking them ...